Segment Information (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014 segments	Mar. 30, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]
Number of Reportable Segments			5
Net sales	$ 1,004,200,000	$ 919,800,000	$ 2,916,600,000	$ 2,572,600,000
Operating Income (Loss)	103,300,000	178,600,000	369,500,000	499,000,000
Intangible assets amortization expense	107,400,000	24,600,000	181,100,000	65,000,000
Assets From Continuing Operations	13,742,700,000		13,742,700,000		4,495,900,000
Consumer Healthcare [Member]
Segment Reporting Information [Line Items]
Net sales	537,300,000	536,800,000	1,612,100,000	1,526,500,000
Operating Income (Loss)	84,400,000	95,900,000	263,800,000	261,300,000
Intangible assets amortization expense	5,300,000	5,000,000	15,900,000	12,200,000
Assets From Continuing Operations	2,555,200,000		2,555,200,000		1,724,600,000
Nutritionals [Member]
Segment Reporting Information [Line Items]
Net sales	137,800,000	133,300,000	406,600,000	358,700,000
Operating Income (Loss)	7,300,000	7,000,000	28,300,000	18,000,000
Intangible assets amortization expense	7,300,000	7,300,000	22,100,000	21,900,000
Assets From Continuing Operations	1,011,500,000		1,011,500,000		951,100,000
Rx Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Net sales	223,400,000	189,400,000	673,600,000	514,900,000
Operating Income (Loss)	77,000,000	73,400,000	260,500,000	206,000,000
Intangible assets amortization expense	17,500,000	11,400,000	55,200,000	28,200,000
Assets From Continuing Operations	1,985,400,000		1,985,400,000		1,433,800,000
API [Member]
Segment Reporting Information [Line Items]
Net sales	32,000,000	41,100,000	105,200,000	118,400,000
Operating Income (Loss)	6,800,000	11,700,000	37,400,000	38,900,000
Intangible assets amortization expense	500,000	500,000	1,600,000	1,400,000
Assets From Continuing Operations	286,800,000		286,800,000		279,000,000
Specialty Sciences [Member]
Segment Reporting Information [Line Items]
Net sales	53,400,000	0	60,800,000	0
Operating Income (Loss)	(54,500,000)	0	(73,500,000)	0
Intangible assets amortization expense	76,400,000	0	85,000,000	0
Assets From Continuing Operations	7,799,500,000		7,799,500,000		0
Other Segments [Member]
Segment Reporting Information [Line Items]
Net sales	20,200,000	19,200,000	58,300,000	54,100,000
Operating Income (Loss)	800,000	1,600,000	2,600,000	2,700,000
Intangible assets amortization expense	400,000	400,000	1,300,000	1,200,000
Assets From Continuing Operations	104,400,000		104,400,000		107,400,000
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Operating Income (Loss)	(18,500,000)	(11,100,000)	(149,700,000)	(27,800,000)
Intangible assets amortization expense	0	0	0	0
Assets From Continuing Operations	$ 0		$ 0		$ 0